Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study

Author:

Diouf Ibrahima,Magliano Dianna J.,Carrington Melinda J.,Stewart Simon,Shaw Jonathan E.

Funder

Commonwealth Dept. of Health and Aged Care

Abbott Australasia Pty Ltd.

Alphapharm Pty Ltd.

AstraZeneca

Aventis Pharmaceutical

Bristol-Myers Squibb Pharmaceuticals

Eli Lilly (Aust) Pty Ltd.

GlaxoSmithKline

Janssen-Cilag (Aust) Pty Ltd.

Merck Lipha s.a.

Merck Sharp & Dohme (Aust)

Novartis Pharmaceutical (Aust) Pty Ltd.

Novo Nordisk Pharmaceutical Pty Ltd.

Pharmacia and Upjohn Pty Ltd.

Pfizer Pty Ltd.

Roche Diagnostics

Sanofi Synthelabo (Aust) Pty Ltd.

Servier Laboratories (Aust) Pty Ltd.

BioRad Laboratories Pty Ltd.

HITECH Pathology Pty Ltd.

Australian Kidney Foundation

Diabetes Australia

Diabetes Australia (Northern Territory)

Queensland Health

South Australian Department of Human Services

Tasmanian Department of Health and Human Services

Territory Health Services

Victorian Department of Human Services

Victorian OIS programme

Health Department of Western Australia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3